Seres Therapeutics, Inc.
MCRB
$9.31
-$0.77-7.64%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -53.92% | -6.19% | -35.93% | -13.11% | -24.69% |
Total Receivables | -- | -- | 150.75% | -- | -- |
Inventory | -- | -- | 26.26% | -- | -- |
Prepaid Expenses | -4.77% | -5.14% | 39.71% | -42.78% | -11.55% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -46.97% | -51.14% | -9.64% | -5.83% | -18.18% |
|
|||||
Total Current Assets | -46.97% | -51.14% | -9.64% | -5.83% | -18.18% |
Net Property, Plant & Equipment | -3.18% | -21.14% | -2.97% | 15.51% | -17.95% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -15.85% | -79.88% | 0.18% | -31.75% | 247.41% |
Total Assets | -21.78% | -44.44% | -5.72% | -4.83% | -2.47% |
|
|||||
Total Accounts Payable | -50.58% | 71.64% | -7.86% | 43.34% | -59.35% |
Total Accrued Expenses | -39.50% | -59.07% | 7.92% | 78.18% | 14.75% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.93% | -9.23% | 4.10% | 58.10% | -11.04% |
Total Finance Division Other Current Liabilities | -41.84% | -40.16% | 15.07% | -33.77% | 50.82% |
Total Other Current Liabilities | -41.84% | -40.16% | 15.07% | -33.77% | 50.82% |
Total Current Liabilities | -36.42% | -40.13% | 9.96% | -0.18% | 24.53% |
|
|||||
Total Current Liabilities | -36.42% | -40.13% | 9.96% | -0.18% | 24.53% |
Long-Term Debt | -- | -- | 0.48% | 0.46% | 0.40% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -2.70% | -15.52% | -2.33% | 12.75% | -12.60% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -61.09% | -95.13% | -0.08% | -12.93% | 14.35% |
Total Liabilities | -18.60% | -62.13% | 1.95% | -0.61% | 5.39% |
|
|||||
Common Stock & APIC | 0.56% | 2.30% | 0.58% | 2.71% | 1.25% |
Retained Earnings | -1.62% | 8.44% | -3.23% | -4.10% | -4.40% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -42.37% | 127.47% | -45.76% | -33.18% | -196.61% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -42.37% | 127.47% | -45.76% | -33.18% | -196.61% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -42.37% | 127.47% | -45.76% | -33.18% | -196.61% |
|